Recent Updates
Recently added Catalysts
CODX Positive Sentiment Score: 70/100

Co-Diagnostics, Inc. Announces First Quarter 2023 Earnings Release Date and Webcast

Friday, May 5, 2023 2 min read
Key Takeaway: Co-Diagnostics, Inc. will release its first quarter 2023 financial results on May 11, 2023. A conference call and webcast will occur at 4:30 p.m. ET to discuss these results with analysts and institutional investors. Management will include the CEO, CFO, and Head of Investor Relations. The results will provide valuable insights into the company's financial health and strategic developments.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of Q1 earnings release indicates transparency and accountability.
  • Engagement with analysts and investors through a conference call suggests investor confidence.
  • Developing patented molecular diagnostic platforms underscores innovation.

Full Press Release Details

SALT LAKE CITY, May 5, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2023 results on Thursday, May 11, 2023, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.
The call and webcast will be available via:
Webcast: ir.codiagnostics.com on the Events & Webcasts page
Conference Call: 844-481-2661 (domestic) or 412-317-0652 (international)
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR Home™ platform and to locate genetic markers for use in applications other than infectious disease.
SOURCE Co-Diagnostics

21 %

more press release views with

Frequently Asked Questions

When will Co-Diagnostics release Q1 2023 results?

Co-Diagnostics will release its Q1 2023 results on May 11, 2023, after market close.

What time is the conference call on May 11, 2023?

The conference call is scheduled for 4:30 p.m. ET on May 11, 2023.

Who will speak during the conference call?

Dwight Egan, Brian Brown, and Andrew Benson will participate in the call.

How can I listen to the conference call?

You can listen via webcast at ir.codiagnostics.com or by calling 844-481-2661.

Will the conference call be recorded?

Yes, if you miss the live event, the call will be recorded and available later.

Tags: CODX Viatris Investor Conferences Healthcare Co-Diagnostics molecular diagnostics earnings release webcast
Last updated: May 5, 2023